The Heparin Market 2020-2024- Featuring Aspen Pharmacare Holdings Ltd., Eisai Co. Ltd., Among Others to Contribute to the Market Growth | Industry Analysis, Market Trends, Opportunities, and Forecast 2024

LONDON--(BUSINESS WIRE)-- The heparin market is poised to grow by USD 941.2 mn during 2020-2024, progressing at a CAGR of almost 3% during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201117006206/en/

Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.

Get FREE Sample Report in Minutes!

The report on the heparin market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the increasing prevalence of chronic conditions.

The heparin market analysis includes product segment and geography landscape. This study identifies the development of drugs to remove heparin after surgery as one of the prime reasons driving the heparin market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The heparin market covers the following areas:

Heparin Market Sizing

Heparin Market Forecast

Heparin Market Analysis

Companies Mentioned

  • Aspen Pharmacare Holdings Ltd.
  • Baxter International Inc.
  • Eisai Co. Ltd.
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals Plc
  • Laboratorios Farmaceuticos Rovi SA
  • Mylan NV
  • Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Sanofi.

Related Reports on Health Care Include:

  • Antifungal Drugs Market by Route of Administration and Geography - Forecast and Analysis 2020-2024 - The antifungal drugs market size has the potential to grow by USD 2.50 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get a FREE sample report in minutes
  • Radiation Oncology Market by Product and Geography - Forecast and Analysis 2020-2024- The radiation oncology market size has the potential to grow by USD 1.70 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get a FREE sample report in minutes

     

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Parent market
  • Market characteristics
  • Market segmentation analysis
  • Value chain analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Low-molecular-weight heparin - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by product

PART 07: MARKET SEGMENTATION BY ROUTE OF ADMINISTRATION

  • Market segmentation by route of administration
  • Comparison by route of administration
  • Subcutaneous injection - Market size and forecast 2019-2024
  • Intravenous/infusion - Market size and forecast 2019-2024
  • Market opportunity by route of administration

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Europe - Market size and forecast 2019-2024
  • North America - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Increasing R&D activities and new therapeutic applications of heparin
  • Advent of biosimilar low-molecular-weight heparin
  • Development of drugs to remove heparin after surgery

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Aspen Pharmacare Holdings Ltd.
  • Baxter International Inc.
  • Eisai Co. Ltd.
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals Plc
  • Laboratorios Farmaceuticos Rovi SA
  • Mylan NV
  • Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Sanofi

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 16: EXPLORE TECHNAVIO

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Source: Technavio Research

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.